Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II. Beird HC, Kannan S, Liu J, Chen J, et al. Leukemia 2026;40:1951-1960.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Beird HC, Kannan S, Liu J, Chen J, et al. Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II. Leukemia 2026;40:1951-1960.
PMID: 42410207